Research Grant Program - Immune Deficiency Foundation supports clinicians and scientists studying primary immunodeficiency to improve diagnosis, treatment, and disease management and advance knowledge.
Funder: Immune Deficiency Foundation
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: $25,000–$50,000 per award for one year
Summary: Supports patient-centered research to improve primary immunodeficiency diagnosis, treatment, health, and disease management, and advance knowledge of PI.
Key Information: Open to U.S.-based academic researchers conducting non-commercial research; proposals using animal models are excluded.
The Immune Deficiency Foundation (IDF) Research Grant Program supports clinicians and scientists conducting patient-centered research on primary immunodeficiency (PI). It funds work aimed at improving treatment, health, disease management, or diagnosis, as well as research that contributes to the broader body of knowledge on PI. The program was established to provide seed funding for well-defined research projects with a specified benefit for people living with these conditions.
Scientific merit guides selection through an independent peer review process modeled on the National Institutes of Health (NIH) system. IDF’s Research Committee, composed of recognized immunologists and past grant awardees, scores proposals and recommends the highest-scoring projects for funding. Recent supported work addresses rare primary immunodeficiencies and the development of diagnostics and treatments.